Erratum (DOI:10.1053/j.jepm.2006.09.009);Meloxicam

Journal of Exotic Pet Medicine

Volumn 15, Issue 4, 2006, Pages 281-283

  Kirchgessner, Megan S ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845269049     PISSN: 15575063     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jepm.2007.02.001     Document Type: Erratum

References (29)

1. Curry S., Cogar S., and Cook J. Nonsteroidal antiinflammatory drugs: a review. J Am Anim Hosp Assoc 41 (2005) 298-309
2. In: Adams H. (Ed). Veterinary Pharmacology and Therapeutics. ed 8. (2001), Iowa State University, Ames, Iowa
3. Bertolini A., Ottani A., and Sandrini A. Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol Res 44 (2001) 437-450
4. Vane J., Bakhle Y., and Botting R. Cyclooxygenase 1 and 2. Ann Rev Pharmacol Toxicol 38 (1998) 97-120
5. Robinson D. Eicosanoids, inflammation, and antiinflammatory drugs. Clin Exp Rheum 7 (1989) 155-161
6. Plumb D. Meloxicam. In: Plumb D.C. (Ed). Veterinary Drug Handbook. ed 4 (2002), Iowa State Press, Ames, IA 490-491
7. Wallace J. Pharm profile: meloxicam. Compend Contin Educ Pract Vet 15 (2003) 64-65
8. Slingsby L. Waterman-Pearson: Comparison between meloxicam and carprofen for postoperative analgesia after feline ovariohysterectomy. J Sm Anim Pract 43 (2002) 286-289
9. Toutain P., Reymond N., Laroute V., et al. Pharmacokinetics of meloxicam in plasma and urine of horses. Am J Vet Res 65 (2004) 1542-1547
10. Priester W., and McKay F. The occurrence of tumors in domestic animals. J Natl Cancer Inst Monogr 54 (1980) 1-210
11. Farrow D., Vaughan T., Hansten P., et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidem 7 (1998) 97-102
12. Tsujii M., Kawano S., and DuBois R. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94 (1997) 3336-3340
13. Tsujii M., Kawano S., Tsuji S., et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93 (1998) 705-719
14. Wolfesberger B., Walter I., Hoelzl C., et al. Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells. Res Vet Sci 80 (2005) 308-316
15. APHIS. Treatment of respiratory disease in US feedlots. Info sheet on veterinary services (2001), United States Department of Agriculture, Fort Collins
16. Ramierz-Romero R., and Brogden K. The potential role of the Arthus and Shwartzman reactions in the pathogenesis of pneumonic pasturellosis. Inflamm Res 49 (2000) 98-101
17. Friton G., Cajal C., and Ramirez-Romero R. Long-term effects of meloxicam in the treatment of respiratory diseases in fattening cattle. Vet Rec 156 (2005) 809-811
18. Crandell D., Mathews K., and Dyson D. Effect of meloxicam and carprofen on renal function when administered to healthy dogs prior to anesthesia and painful stimulation. Am J Vet Res 65 (2004) 1384-1390
19. Fresno L., Moll J., Penalba B., et al. Effects of preoperative administration of meloxicam on whole blood platelet aggregation, buccal mucosal bleeding time, and haematolgoical indices in dogs undergoing elective ovariohysterectomy. Vet J 170 (2005) 138-140
20. Pereira M., and Werther K. Comparative evaluation of the renal effects of a seven-day therapy with flunixin meglumine, ketoprofen and meloxicam in budgerigar (Melopsittacus undutatus). Proc Annu Conf AAZV, AAWV, WDA (2004) 610-612
21. Laudanno O., Cesolari J., Esnarriaga M., et al. In vivo selectivity of nonsteroidal antiinflammatory drugs and gastrointestinal ulcers in rats. Dig Dis Sci 45 (2000) 1359-1365
22. Wilson G., Hernandez-Divers S., Budsber S., et al. Pharmacokinetics and use of meloxicam in psittacine birds. Proc Annu Conf Assoc Avi Vet (2004) 7-9
23. Lees P., Sedgewick A., Higgins A., et al. Pharmacodynamics and pharmacokinetics of meloxicam in the horse. Br Vet J 147 (1991) 97-108
24. Schmid J., Busch U., Heinzel G., et al. Pharmacokinetics and metabolic pattern of meloxicam after intravenous infusion and oral administration to healthy subjects. Drug Metab Dispos 23 (1995) 1206-1213
25. Baert K., Nackaerts J., and De Backer P. Disposition of sodium salicylate, flunixin, and meloxicam after intravenous administration in ostriches (Struthio camelus). J Av Med Surg 16 (2002) 123-128
26. Baert K., and De Backer P. Comparative pharmacokinetics of three non-steroidal anti-inflammatory drugs in five bird species. Comp Biochem Physiol 134 (2003) 25-33
27. Turner P., Chen H., and Taylor W. Pharmacokinetics of meloxicam in rabbits after single and repeat oral dosing. Comp Med 56 (2006) 63-67
28. Busch U., Schmid J., Heinzel G., et al. Pharmacokinetics of meloxicam in animals and the relevance to humans. Drug Metab Disp 26 (1998) 576-584
29. Hernandez-Divers S. Single-dose oral and intravenous pharmacokinetics of meloxicam in the green iguana (Iguana iguana). Proc Annu Conf ARAV (2004) 106-107